دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Association of Lipoprotein(a) With Atherosclerotic Plaque Progression
YannickKaiserMDa∗MarwaDaghemMDb∗EvangelosTzolosMDbMohammed N.MeahMDbMhairi K.DorisMD, PhDbAlistair J.MossMD, PhDcJacekKwiecinskidJeffreyKroonPhDeNick S.NurmohamedMDafPimvan der HarstMD, PhDgPhilip D.AdamsonMD, PhDbhMichelle C.WilliamsMD, PhDbDaminiDeyiDavid E.NewbyMD, PhDbErik S.G.StroesMD, PhDaKang H.ZhengMD, PhDaMarc R.DweckMD, PhDb
doi : 10.1016/j.jacc.2021.10.044
Volume 79, Issue 3, 25 January 2022, Pages 223-233
Lipoprotein(a) [Lp(a)] is associated with increased risk of myocardial infarction, although the mechanism for this observation remains uncertain.
Lipoprotein(a) and CT Angiography: Novel Insights Into High-Risk Plaque Progression∗
SotiriosTsimikasMDaJagatNarulaMD, PhDb
doi : 10.1016/j.jacc.2021.11.015
Volume 79, Issue 3, 25 January 2022, Pages 234-237
Evolution of Incidence, Management, and Outcomes Over Time in Sports-Related Sudden Cardiac Arrest
NicoleKaramMD, PhDabcLouisPechmajouMD, MPHabcKumarNarayananMDabdWulfranBougouinMD, PhDabeArdalanSharifzadehganMD, MPHaSorayaAnysMD, MScabcOrianneWeizmanMD, MPHabDavidPerrotMD, MPHabcVictorWaldmannMD, PhDabcFrankieBegantonMPHabMarie-CécilePerierMPHabJulienRischardMD, MPHabcThomasLoebMDbfJean-MarcAgostinucciMDbgEricLecarpentierMDbhPatriciaJabreMD, PhDabiDanielJostMD, PhDabjFlorenceDumasMD, PhDabk…EloiMarijonMD, PhDabc∗
doi : 10.1016/j.jacc.2021.11.011
Volume 79, Issue 3, 25 January 2022, Pages 238-246
Major efforts have been made to reduce the burden of sports-related sudden cardiac arrest (SrSCA). The extent to which the incidence, management, and outcomes changed over time has not been investigated.
Sudden Cardiac Arrest in Sport: Reactive Success Versus Proactive Failure?∗
Michael J.AckermanMD, PhDaJohn R.GiudicessiMD, PhDb
doi : 10.1016/j.jacc.2021.11.012
Volume 79, Issue 3, 25 January 2022, Pages 247-249
Lifetime Risk of Heart Failure Among Participants in the Framingham Study
Ramachandran S.VasanMDabcDanielle M.EnserroPhDdAlexa S.BeiserPhDaeVanessaXanthakisPhDabe
doi : 10.1016/j.jacc.2021.10.043
Volume 79, Issue 3, 25 January 2022, Pages 250-263
The residual lifetime risk (RLR) of developing heart failure (HF) may have changed over time because of the increasing population burden of hypertension, obesity, and diabetes; greater survival after myocardial infarction; and a greater lifespan.
Change in Lifetime Risk of Heart Failure: Applicable to All?∗
Mary NorineWalshMD
doi : 10.1016/j.jacc.2021.11.014
Volume 79, Issue 3, 25 January 2022, Pages 264-266
Rural-Urban Disparities in Outcomes of Myocardial Infarction, Heart Failure, and Stroke in the United States
Eméfah C.LoccohMDabKaren E.Joynt MaddoxMD, MPHcYunWangPhDaDhruv S.KaziMD, MSaRobert W.YehMD, MScaRishi K.WadheraMD, MPP, MPhila
doi : 10.1016/j.jacc.2021.10.045
Volume 79, Issue 3, 25 January 2022, Pages 267-279
U.S. policy efforts have focused on reducing rural-urban health inequities. However, it is unclear whether gaps in care and outcomes remain among older adults with acute cardiovascular conditions.
Rural-Urban Disparities in Cardiovascular Outcomes: Getting to the Root of the Problem∗
Alexander C.FanaroffMD, MHSaPeter T.EvansMDbAshwin S.NathanMD, MSHPa
doi : 10.1016/j.jacc.2021.11.016
Volume 79, Issue 3, 25 January 2022, Pages 280-282
Lessons Learned From 10 Years of Preschool Intervention for Health Promotion: JACCÂ State-of-the-Art Review
GloriaSantos-BeneitPhDabcRodrigoFernández-JiménezMD, PhDcdeAmayade Cos-GandoyMScacCarlaRodrÃguezMScaVanesaCarralPhDaPatriciaBodegaMScacMercedesde MiguelMScacXavierOrritPhDaDomenecHaroBAaJosé L.PeñalvoPhDfJuan MiguelFernández-AlviraPhDcCarlesPeyraBA, MBAabJaime A.CéspedesMDghAlexandraTurcoBSbMarilynHunnBSbRisaJaslowMS, RDNbJorgeBaxterPhDiIsabelCarvajalMScaValentinFusterMD, PhDabc
doi : 10.1016/j.jacc.2021.10.046
Volume 79, Issue 3, 25 January 2022, Pages 283-298
Implementing a health promotion program for children is a complex endeavor. In this review, we outline the key lessons learned over 10 years of experience in implementing the SI! Program (Salud Integral–Comprehensive Health) for cardiovascular health promotion in preschool settings in 3 countries: Colombia (Bogotá), Spain (Madrid), and the United States (Harlem, New York). By matching rigorous efficacy studies with implementation science, we can help bridge the divide between science and educational practice. Achieving sustained lifestyle changes in preschool children through health promotion programs is likely to require the integration of several factors: 1) multidisciplinary teams; 2) multidimensional educational programs; 3) multilevel interventions; 4) local program coordination and community engagement; and 5) scientific evaluation through randomized controlled trials. Implementation of effective health promotion interventions early in life may induce long-lasting healthy behaviors that could help to curb the cardiovascular disease epidemic.
Lead-Related Venous Obstruction in Patients With Implanted Cardiac Devices: JACC Review Topic of the Week
PeterZimetbaumMDaBrett J.CarrollMDaAndrew H.LockeMDaEricSecemskyMD, MScaMarcSchermerhornMDb
doi : 10.1016/j.jacc.2021.11.017
Volume 79, Issue 3, 25 January 2022, Pages 299-308
Cardiac implantable electronic device implantation rates have increased in recent decades. Venous obstruction of the subclavian, brachiocephalic, or superior vena cava veins represents an important complication of implanted leads. These forms of venous obstruction can result in significant symptoms as well as present a barrier to the implantation of additional device leads. The risk factors for the development of these complications remain poorly understood, and diagnosis relies on clinical recognition and cross-sectional imaging. Anticoagulation remains the mainstay of treatment, and thrombus debulking, lead extraction, venoplasty, and stenting are all important therapeutic interventions. This review provides a multidisciplinary-based approach to the evaluation and management of cardiac implantable electronic device lead-associated venous obstruction.
Physical Activity Among Patients With Intracardiac Remote Monitoring Devices Before, During, and After COVID-19–Related Restrictions
YuanLuScDPaul W.JonesMSKarthikMurugiahMDCésarCaraballoMDDaisy S.MasseyBAShiwaniMahajanMBBS, MHSRezwanAhmedPhDEric M.BaderMDHarlan M.KrumholzMD, SM
doi : 10.1016/j.jacc.2021.11.010
Volume 79, Issue 3, 25 January 2022, Pages 309-310
Navigating a Career in Innovation
NabilDibMD, MScAnthony M.DeMariaMDSpencer B.KingIIIMD
doi : 10.1016/j.jacc.2021.08.077
Volume 79, Issue 3, 25 January 2022, Pages e141-e142
Reply: Navigating a Career in Innovation
Ahmed M.A.SelimMDChirag R.BarbhaiyaMD
doi : 10.1016/j.jacc.2021.11.013
Volume 79, Issue 3, 25 January 2022, Pages e143-e144
